271 related articles for article (PubMed ID: 28552060)
1. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
Asadov C; Aliyeva G; Mustafayeva K
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden.
Zimdahl Kahlin A; Helander S; Skoglund K; Söderkvist P; Mårtensson LG; Appell ML
Biochem Pharmacol; 2019 Jun; 164():263-272. PubMed ID: 31005613
[TBL] [Abstract][Full Text] [Related]
3. Implementation of TPMT testing.
Lennard L
Br J Clin Pharmacol; 2014 Apr; 77(4):704-14. PubMed ID: 23962279
[TBL] [Abstract][Full Text] [Related]
4. Development of a rapid clinical TPMT genotyping assay.
Burchard PR; Abou Tayoun AN; Lefferts JA; Lewis LD; Tsongalis GJ; Cervinski MA
Clin Biochem; 2014 Oct; 47(15):126-9. PubMed ID: 25093923
[TBL] [Abstract][Full Text] [Related]
5. Establishment of thiopurine S-methyltransferase gene knockdown in jurkat T-lymphocytes: an in vitro model of TPMT polymorphism.
Misdaq M; Andag R; Oellerich M; Asif AR; von Ahsen N
Ther Drug Monit; 2012 Oct; 34(5):584-92. PubMed ID: 22972540
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.
Larussa T; Suraci E; Lentini M; Nazionale I; Gallo L; Abenavoli L; Imeneo M; Costanzo FS; Cuda G; Luzza F
Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887
[TBL] [Abstract][Full Text] [Related]
7. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
[TBL] [Abstract][Full Text] [Related]
8. Reducing risk in thiopurine therapy.
Marinaki AM; Arenas-Hernandez M
Xenobiotica; 2020 Jan; 50(1):101-109. PubMed ID: 31682552
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacogenomics of thiopurine S-methyltransferase.
Zhou S
Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
[TBL] [Abstract][Full Text] [Related]
10. Modeling the Outcome of Systematic TPMT Genotyping or Phenotyping Before Azathioprine Prescription: A Cost-Effectiveness Analysis.
Zarca K; Durand-Zaleski I; Loriot MA; Chatellier G; Pallet N
Mol Diagn Ther; 2019 Jun; 23(3):429-438. PubMed ID: 30963516
[TBL] [Abstract][Full Text] [Related]
11. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.
Schaeffeler E; Jaeger SU; Klumpp V; Yang JJ; Igel S; Hinze L; Stanulla M; Schwab M
Genet Med; 2019 Sep; 21(9):2145-2150. PubMed ID: 30728528
[TBL] [Abstract][Full Text] [Related]
12. Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.
van Aken J; Schmedders M; Feuerstein G; Kollek R
Am J Pharmacogenomics; 2003; 3(3):149-55. PubMed ID: 12814323
[TBL] [Abstract][Full Text] [Related]
13. Nomenclature for alleles of the thiopurine methyltransferase gene.
Appell ML; Berg J; Duley J; Evans WE; Kennedy MA; Lennard L; Marinaki T; McLeod HL; Relling MV; Schaeffeler E; Schwab M; Weinshilboum R; Yeoh AE; McDonagh EM; Hebert JM; Klein TE; Coulthard SA
Pharmacogenet Genomics; 2013 Apr; 23(4):242-8. PubMed ID: 23407052
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine S-methyltransferase testing for averting drug toxicity: a meta-analysis of diagnostic test accuracy.
Zur RM; Roy LM; Ito S; Beyene J; Carew C; Ungar WJ
Pharmacogenomics J; 2016 Aug; 16(4):305-11. PubMed ID: 27217052
[TBL] [Abstract][Full Text] [Related]
15. Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic Variants.
Beránek M; Drastíková M; Bureš J; Palička V
Folia Biol (Praha); 2015; 61(3):91-6. PubMed ID: 26213853
[TBL] [Abstract][Full Text] [Related]
16. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
Relling MV; Gardner EE; Sandborn WJ; Schmiegelow K; Pui CH; Yee SW; Stein CM; Carrillo M; Evans WE; Klein TE;
Clin Pharmacol Ther; 2011 Mar; 89(3):387-91. PubMed ID: 21270794
[TBL] [Abstract][Full Text] [Related]
17. Safe azathioprine treatment in a pediatric ulcerative colitis patient with TPMT*16 by thiopurine metabolite monitoring.
Kim HY; Kim JW; Kim MJ; Lee YM; Kang B; Choe YH; Lee SY
Clin Chim Acta; 2014 Nov; 437():101-2. PubMed ID: 25036765
[No Abstract] [Full Text] [Related]
18. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
Dervieux T; Meyer G; Barham R; Matsutani M; Barry M; Boulieu R; Neri B; Seidman E
Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the pharmacogenomics of thiopurine methyltransferase.
Coulthard SA; Hall AG
Pharmacogenomics J; 2001; 1(4):254-61. PubMed ID: 11908768
[TBL] [Abstract][Full Text] [Related]
20. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]